Vorozhtsov Institute of Organic Chemistry, Siberian Division, Russian Academy of Sciences, Prospect Akademika Lavrent'eva 9, Novosibirsk, 630090, Russian Federation.
Curr Med Chem. 2021;28(30):6234-6273. doi: 10.2174/0929867328666210614122444.
Pain is a symptom of ninety percent of human diseases, and pain management is a very important medicinal problem. Various modulators of the pain response have been detected, and analgesic effects are obtained by increasing inhibition or decreasing excitation in the nervous system. Various known analgesic drugs are commonly used to relieve the pain; however, this problem is still not fully resolved by currently available treatments. Available analgesic drugs (non-steroidal anti-inflammatory drugs, opioids and analgesic adjuvants) are not too effective and are severely limited by adverse effects, for example, opioid addiction. Therefore, developing effective pain management is a difficult but necessary task. Thus, there is an urgent need for further development of the design and synthesis of new analgesic agents. The aim of this review is to present recent progress in search of new small molecule analgesics. The structures and effects of new perspective analgesic agents (anti-inflammatory agents, opioid analgesics, adjuvant agents for pain management, and natural compounds) are presented and discussed. The review covers the literature published in 2015-2020 years and includes 173 references.
疼痛是 90%人类疾病的症状,疼痛管理是一个非常重要的医学问题。已经发现了各种疼痛反应的调节剂,通过增加神经系统的抑制或减少兴奋来获得镇痛效果。各种已知的镇痛药通常用于缓解疼痛;然而,目前可用的治疗方法仍未完全解决这一问题。现有的镇痛药(非甾体抗炎药、阿片类药物和镇痛佐剂)效果不太理想,并受到严重的副作用限制,例如阿片类药物成瘾。因此,开发有效的疼痛管理是一项困难但必要的任务。因此,迫切需要进一步设计和合成新的镇痛药。本文旨在介绍寻找新型小分子镇痛药的最新进展。介绍并讨论了新型有前景的镇痛药(抗炎药、阿片类镇痛药、疼痛管理佐剂和天然化合物)的结构和作用。综述涵盖了 2015 年至 2020 年发表的文献,包括 173 篇参考文献。